CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Aslam Shakil Chief Medical Officer | Shares withheld for taxes | −4,518 | $0.82 | $4K | 76,542 |
| 2026-04-02 | Aslam Shakil Chief Medical Officer | Shares withheld for taxes | −2,118 | $0.72 | $2K | 81,060 |
| 2026-02-12 | Aslam Shakil Chief Medical Officer | Purchase | +35,000 | $0.81 | $28K | 83,178 |
| 2026-02-12 | Aslam Shakil Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +205,000 | 205,000 | ||
| 2025-05-20 | Aslam Shakil Chief Medical Officer | Shares withheld for taxes | −4,517 | $0.52 | $2K | 48,178 |
| 2025-04-02 | Aslam Shakil Chief Medical Officer | Grant or award | +15,000 | 52,695 | ||
| 2025-04-02 | Aslam Shakil Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2024-06-14 | Aslam Shakil Chief Medical Officer | Purchase | +5,000 | $1.07 | $5K | 37,695 |
| 2024-06-13 | Aslam Shakil Chief Medical Officer | Purchase | +695 | $0.98 | $681 | 32,695 |
Page 1 of 1 · 9 trades